Every batch intake form has a box for purity, and every box tends to acquire more authority than the number inside it deserves. A figure of 99% or above looks definitive — a clean, single verdict on a vial that is about to be logged, labelled and shelved. In practice, an HPLC purity result is a measurement of one property, taken under one set of conditions, on one sample. Understanding where that measurement starts and stops is what separates a well-documented store from a shelf of unexamined assumptions.
High-performance liquid chromatography separates the components of a sample as they pass through a column, and the purity value is usually calculated from integrated peak area: the area of the main peak expressed as a percentage of total detected peak area. That definition matters, because it frames the number as a comparison rather than an absolute statement about what is in the vial.
The Purity Percentage Is a Relative Measurement, Not an Absolute Verdict
Method-bound by design
The same sample can produce different purity figures on different systems. Column chemistry, particle size, gradient shape, mobile-phase composition, flow rate, detection wavelength and sample concentration all influence how peaks resolve and how the integration boundaries are drawn. A method optimised for one peptide may separate closely related impurities beautifully; a generic gradient run on the same material may merge them into the main peak and report a figure that flatters the sample. When a research group books a batch into stores, the purity figure should therefore be read as the result of a stated method, not as an intrinsic property of the material that travels independently of how it was measured.
This is why the batch Certificate of Analysis (CoA) matters more than a headline claim on a product page. Research Sciences describes peptides as typically supplied at ≥99% purity, HPLC tested, with the exact purity stated on the CoA, and the homepage refers to ≥99% verified purity and materials over 99.1% purity. Those are the shop’s published figures at the time of writing and should be reconfirmed on the live site — but for intake purposes, the only figure that counts is the one printed on the document linked to the batch in your hand.
Area percent is not mass percent
An area-percentage purity figure does not account for everything that might be present. Components that do not absorb at the detection wavelength, inorganic salts, residual water and material retained on the column can all sit outside the integration window. Equally, a peak can be homogenous in a chromatogram while containing more than one species. For a stores manager, the practical implication is simple: the percentage is a screening gate, useful for flagging an obvious outlier, but it is not a substitute for reading the rest of the documentation before the batch is released to a researcher.
What the Figure Cannot Tell You About a Batch
Identity, related substances and co-elution
A purity percentage says nothing on its own about whether the main peak is the compound you ordered. Identity is a separate question, usually addressed through retention-time comparison against a reference standard, mass confirmation or related techniques. The shop’s FAQ states that each compound includes a CoA covering purity and identity by HPLC, with independent testing and final UK verification before release; the homepage lists CoAs as Janoshik Analytical Reports. Treat those as the shop’s description, and always open the actual document to see what was tested and how.
Related substances deserve similar scrutiny. Structurally similar analogues, diastereomers and truncated sequences can, under an unsuitable method, elute close enough to the main peak to be integrated as part of it. A 99% figure generated by a method that cannot resolve a near-neighbour impurity is not equivalent to a 99% figure generated by a method that can. The number alone will not tell you which situation you are looking at.
Endotoxin, heavy metals and quantity in the vial
Chromatographic purity is silent on contaminants that require entirely different analytical approaches. Research Sciences describes an expanded testing framework covering heavy metals and endotoxin screening alongside CoA documentation, presented as full-spectrum evaluation of submitted samples. A research group booking material into stores should confirm which tests accompany the specific batch, rather than assuming that a purity figure implies contaminant screening.
Nor does the percentage describe how much material is in the vial. Fill weight, moisture content and the presence of excipients are separate matters; the FAQ notes that peptides contain trace amounts of mannitol, used for stability during lyophilisation and to aid solubility. Reconstitution calculations for an in-vitro assay should be built from the stated vial content and the CoA, not inferred from a purity claim.
Internal Test References and the restocking trap
The FAQ makes a point worth repeating at intake: restocked products may carry the same Internal Test Reference (ITR) as earlier stock. An ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or that they have been independently tested separately. Vial cap colours and packaging can also vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. Two vials that look identical on the shelf may therefore have quite different documentary histories.
Booking In: Checks a Research Group Should Run Before Shelving
The first step is to match paperwork to product. Vial labels use a reference combining the SKU code and expiry date, for example BPC10-03/27, and that reference links to the corresponding CoA. Quote it when contacting the shop about documentation. Before anything is entered into the stores ledger, confirm that the CoA reference, the label reference and the intake record agree, and that the tests listed on the certificate cover the questions your research workflow actually depends on.
Second, quarantine pending documentation review. A batch that has arrived but whose CoA has not been opened is not yet ready for release to a bench. Groups ordering from UK catalogues such as Uk peptides will typically find CoA documentation published alongside listed items, but the document tied to the specific batch remains the authoritative record, and the published headline figures should be reconfirmed rather than assumed. Research Sciences is described in its FAQ as the parent company of Imperial Peptides UK, which continues as a brand, so older documentation may carry either name.
Third, log storage conditions at the point of intake. The site’s handling guidance is to store lyophilised peptides at −20°C or below, sealed with desiccant and protected from moisture, heat and light, avoiding repeated freeze–thaw cycles. Allow vials to reach room temperature before opening, work in a clean environment, and remove only the amount required for the experiment. Where material is reconstituted for an in-vitro assay, the guidance is short-term storage at 2–8°C, with diluent volumes calculated from the stated vial content; the shop’s reconstitution calculator is a laboratory tool and is not intended for any other purpose.
Fourth, record the intended use and the compliance position. All materials supplied by Research Sciences are research-use-only, labelled “For Research Use Only – Not for Human Consumption”, and are not for human or veterinary use, consumption, administration or clinical application. The purchaser is responsible for lawful use, safe handling, storage and disposal, and for compliance with COSHH and laboratory safety standards. Blended peptides are not supplied, so any combination step belongs inside a controlled experimental design, documented separately from the batch record.
A purity figure earns its place on the intake form — it is a fast, useful signal that something is broadly as expected. It simply cannot carry the whole story. The CoA, the label reference, the storage log and the stated research purpose are what turn a number into a documented, auditable batch record for materials that are, and remain, not for human or veterinary use.
Born in the coastal city of Mombasa, Kenya, and now based out of Lisbon, Portugal, Aria Noorani is a globe-trotting wordsmith with a degree in Cultural Anthropology and a passion for turning complex ideas into compelling stories. Over the past decade she has reported on blockchain breakthroughs in Singapore, profiled zero-waste chefs in Berlin, live-blogged esports finals in Seoul, and reviewed hidden hiking trails across South America. When she’s not writing, you’ll find her roasting single-origin coffee, sketching street architecture, or learning the next language on her list (seven so far). Aria believes that curiosity is borderless—so every topic, from quantum computing to Zen gardening, deserves an engaging narrative that sparks readers’ imagination.